Re: Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability [4]

Journal of the National Cancer Institute

Volumn 99, Issue 6, 2007, Pages 489-490

  Etzioni, Ruth D ^a   Ankerst, Donna P ^a   Thompson, Ian M ^b  

^a USA   (United States)

^b University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; AREA UNDER THE CURVE; CANCER DIAGNOSIS; CANCER GRADING; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY DIAGNOSIS; HAZARD RATIO; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; RISK REDUCTION; ROC CURVE; SENSITIVITY AND SPECIFICITY; BLOOD; IMMUNOLOGY; MALE; NOTE; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; SURVIVAL;

HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 34047249065     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk100     Document Type: Letter

References (3)

1. Carter HB, Ferrucci L, Kettermann A, Landis P, Wright EJ, Epstein JI, et al. Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst 2006;98: 1521-7.
2. Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, et al. Assessing prostate cancer risk: Results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2006;98:529-34.
3. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 2004;350:2239-46.